Stellate Ganglion Block in the Management of Recurrent Ventricular Tachycardia*Corresponding Author: Gabriel Nam, Department of Anesthesiology and Critical Care, Hospital of the University of Pennsylvania, USA, Tel: 2675929752, Email: [email protected]
Received Date: Jan 20, 2019 / Accepted Date: Feb 18, 2019 / Published Date: Feb 25, 2019
Citation: Nam G, Singh R (2019) Stellate Ganglion Block in the Management of Recurrent Ventricular Tachycardia. J Pain Relief 8:341.
Copyright: © 2019 Nam G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recurrent ventricular arrhythmias are clinically challenging cases. Patients frequently have been trialed on a variety of antiarrhythmic medications, and symptomatic cases ultimately require invasive interventions with the utilization of multiple resources. In this report, we present a 61-year-old African American male admitted to an intensive care unit with nonischemic cardiomyopathy and persistent hemodynamically unstable ventricular tachycardia successfully managed with a bilateral stellate ganglion block. He had previously been trialed on a number of antiarrhythmic medications, cardioversions, and ablations. While not commonly considered first-line therapy, stellate ganglion blocks are a promising intervention in the management of incessant ventricular tachycardia. Larger studies will be required to determine a possible role of stellate ganglion blocks in the treatment of ventricular arrhythmias.